JAK2 and B-cell chronic lymphocytic leukemia: Since IL-6 is one of the main activator of JAK2/STAT3 pathway, and one of the most representative cytokines released by the bone marrow in CLL [14], we analyzed the influence of IL-6 on CLL cells.